Co-Diovan 160mg/25mg film-coated tablets Malta - Englisch - Medicines Authority

co-diovan 160mg/25mg film-coated tablets

novartis ireland limited vista building, elm park, merrion road, ballsbridge, dublin 4,, ireland - hydrochlorothiazide, valsartan - film-coated tablet - hydrochlorothiazide 25 mg valsartan 160 mg - agents acting on the renin-angiotensin system

Co-Diovan Tab 12.5 mg, 80 mg Jordanien - Englisch - JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)

co-diovan tab 12.5 mg, 80 mg

شركة مستودع الأدوية الأردني - the jordan drugstore co - hydrochlorothiazide 12.5 mg, valsartan 80 mg - 12.5 mg, 80 mg

DIOVAN Brasilien - Portugiesisch - ANVISA (Agência Nacional de Vigilância Sanitária)

diovan

novartis biociencias s.a - valsartana - anti-hipertensivos simples

DIOVAN- valsartan tablet Vereinigte Staaten - Englisch - NLM (National Library of Medicine)

diovan- valsartan tablet

physicians total care, inc. - valsartan (unii: 80m03yxj7i) (valsartan - unii:80m03yxj7i) - valsartan 40 mg - diovan® (valsartan) is indicated for the treatment of hypertension, to lower blood pressure. lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. these benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including the class to which valsartan principally belongs. there are no controlled trials in hypertensive patients demonstrating risk reduction with diovan. control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise, and limited sodium intake. many patients will require more than one drug to achieve blood pressure goals. for specific advice on goals and management, see published guidelines, such as those of the national high blood pressure education program’s joint national committee on prevention, detection, evaluati

Valsartan + Hidroclorotiazida Denk 80 mg + 12.5 mg Comprimido revestido por película Portugal - Portugiesisch - INFARMED (Autoridade Nacional do Medicamento e Produtos de Saúde)

valsartan + hidroclorotiazida denk 80 mg + 12.5 mg comprimido revestido por película

denk pharma gmbh & co. kg - valsartan + hidroclorotiazida - comprimido revestido por película - 80 mg + 12.5 mg - valsartan 80 mg ; hidroclorotiazida 12.5 mg - valsartan and diuretics - genérico - duração do tratamento: longa duração

Valsartan + Hidroclorotiazida Denk 80 mg + 12.5 mg Comprimido revestido por película Portugal - Portugiesisch - INFARMED (Autoridade Nacional do Medicamento e Produtos de Saúde)

valsartan + hidroclorotiazida denk 80 mg + 12.5 mg comprimido revestido por película

denk pharma gmbh & co. kg - valsartan + hidroclorotiazida - comprimido revestido por película - 80 mg + 12.5 mg - valsartan 80 mg ; hidroclorotiazida 12.5 mg - valsartan and diuretics - genérico - duração do tratamento: longa duração

Valsartan + Hidroclorotiazida Denk 80 mg + 12.5 mg Comprimido revestido por película Portugal - Portugiesisch - INFARMED (Autoridade Nacional do Medicamento e Produtos de Saúde)

valsartan + hidroclorotiazida denk 80 mg + 12.5 mg comprimido revestido por película

denk pharma gmbh & co. kg - valsartan + hidroclorotiazida - comprimido revestido por película - 80 mg + 12.5 mg - valsartan 80 mg ; hidroclorotiazida 12.5 mg - valsartan and diuretics - genérico - duração do tratamento: longa duração

DIOVAN- valsartan tablet Vereinigte Staaten - Englisch - NLM (National Library of Medicine)

diovan- valsartan tablet

novartis pharmaceuticals corporation - valsartan (unii: 80m03yxj7i) (valsartan - unii:80m03yxj7i) - valsartan 40 mg - diovan® is indicated for the treatment of hypertension, to lower blood pressure in adults and pediatric patients one year of age and older. lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. these benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes, including the class to which valsartan principally belongs. there are no controlled trials in hypertensive patients demonstrating risk reduction with diovan. control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise, and limited sodium intake. many patients will require more than one drug to achieve blood pressure goals. for specific advice on goals and management, see published guidelines, such as those of the national high blood pressure education program’s joint nation

DIOVAN- valsartan tablet Vereinigte Staaten - Englisch - NLM (National Library of Medicine)

diovan- valsartan tablet

pd-rx pharmaceuticals, inc. - valsartan (unii: 80m03yxj7i) (valsartan - unii:80m03yxj7i) - valsartan 160 mg - diovan ® is indicated for the treatment of hypertension, to lower blood pressure in adults and pediatric patients one year of age and older. lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. these benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes, including the class to which valsartan principally belongs. there are no controlled trials in hypertensive patients demonstrating risk reduction with diovan. control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise, and limited sodium intake. many patients will require more than one drug to achieve blood pressure goals. for specific advice on goals and management, see published guidelines, such as those of the national high blood pressure education progr

DIOVAN- valsartan tablet Vereinigte Staaten - Englisch - NLM (National Library of Medicine)

diovan- valsartan tablet

pd-rx pharmaceuticals, inc. - valsartan (unii: 80m03yxj7i) (valsartan - unii:80m03yxj7i) - diovan ® is indicated for the treatment of hypertension, to lower blood pressure in adults and pediatric patients one year of age and older. lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. these benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes, including the class to which valsartan principally belongs. there are no controlled trials in hypertensive patients demonstrating risk reduction with diovan. control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise, and limited sodium intake. many patients will require more than one drug to achieve blood pressure goals. for specific advice on goals and management, see published guidelines, such as those of the national high blood pressure education progr